论文部分内容阅读
目的：剂量密集化疗方案相对常规3周方案能提高乳腺癌辅助化疗患者的生存，而在新辅助化疗方面研究较少。因此，我们进行了一项Ⅱ期的临床研究，探讨紫杉醇联合卡铂加或不加曲妥珠单抗(依照患者的HER2状态)两周剂量密集方案在早期乳腺癌新辅助化疗中的疗效以及安全性。
紫杉醇联合卡铂剂量密集方案在乳腺癌新辅助化疗中的应用
【摘 要】
：
目的：剂量密集化疗方案相对常规3周方案能提高乳腺癌辅助化疗患者的生存，而在新辅助化疗方面研究较少。因此，我们进行了一项Ⅱ期的临床研究，探讨紫杉醇联合卡铂加或不加曲妥
【机 构】
：
广州 广东省人民医院乳腺科
【出 处】
：
第十八届全国临床肿瘤学大会暨2015年CSCO学术年会
【发表日期】
：
2015年期
其他文献
Clinical outcomes following neoadjuvant nab-paclitaxel and cisplatin chemotherapy for locally advanc
目的： The combination of nab-paclitaxel and cisplatin as preoperative treatment for esophageal squamous cell carcinoma (ESCC) has not been investigated.
Objective: Although it has been shown that polymorphisms in one-carbon metabolism (OCM) pathway are associated with gastric cancer (GC), their interactions
会议
Nomograms based clinical parameters predicting early response for locally advanced rectal cancer wit
Objective: To avoid the damage of radiotherapy for rectal cancer patients, we have designed a phase Ⅱ study comparing Neoadjuvant mFOLFOX6 chemotherapy wit
会议
Circulating tumor cells early predict prognosis of hepatocellular carcinoma treated with transarteri
Objective: To evaluate the potential utility of circulating tumor cells (CTCs) measurements in predicting prognosis of hepatocellular carcinoma (HCC) patien
会议
Prospective Randomized Phase Ⅱ Study of FOLFIRI versus FOLFOX7 in Advanced Gastric Adenocarcinoma: a
Objective: The purpose was to compare folinic acid, 5-fluorouracil (5-FU), and irinotecan (mFOLFIRI;arm A) with folinic acid, 5-FU, and oxaliplatin (mFOLFOX
会议
Nomogram and Recursive Partitioning Analysis to Determine the Risk of Cancer-Specific Survival for P
Objective: Whether adjuvant chemoradiotherapy (ACRT) or chemotherapy (ACT) will benefit for stage Ⅱ or Ⅲ upper rectal cancer (URC) after radical surgery r
会议
Laparoscopic versus open abdominal peritoneal resection for rectal cancer: a case-matched study of p
Objective: The aim of the study is to evaluate the safety and feasibility of laparoscopic abdominal peritoneal resection (LAPR) for rectal cancer compared w
会议
目的：探讨富含半胱氨酸的分泌性酸性蛋白(SPARC)在三阴性乳腺癌(TNBC)肿瘤组织的表达及其与预后的相关性。方法：收集2004年至2008年在我院行乳腺癌手术的211例三阴性乳腺癌
Objective: Proposed a new IMRT treatment planning technique with the potential of reducing low dose region of the lungs in esophageal cancer patients treate
会议